Sino Biopharmaceutical (Sino Biopharmaceutical) PB Ratio : 1.39 (As of Apr. 26, 2024)

View and export this data going back to 2010. Start your Free Trial

What is Sino Biopharmaceutical PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-26), Sino Biopharmaceutical's share price is $0.31495. Sino Biopharmaceutical's Book Value per Share for the quarter that ended in Jun. 2023 was $0.23. Hence, Sino Biopharmaceutical's PB Ratio of today is 1.39.

The historical rank and industry rank for Sino Biopharmaceutical's PB Ratio or its related term are showing as below:

SBMFF' s PB Ratio Range Over the Past 10 Years
Min: 1.33 Med: 5.95 Max: 13.23
Current: 1.58

During the past 13 years, Sino Biopharmaceutical's highest PB Ratio was 13.23. The lowest was 1.33. And the median was 5.95.

SBMFF's PB Ratio is ranked better than
65.95% of 1310 companies
in the Biotechnology industry
Industry Median: 2.385 vs SBMFF: 1.58

During the past 12 months, Sino Biopharmaceutical's average Book Value Per Share Growth Rate was -7.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 26.10% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 25.40% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 21.10% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Sino Biopharmaceutical was 75.30% per year. The lowest was -30.70% per year. And the median was 18.30% per year.

Back to Basics: PB Ratio

Sino Biopharmaceutical PB Ratio Historical Data

The historical data trend for Sino Biopharmaceutical's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sino Biopharmaceutical PB Ratio Chart

Sino Biopharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

PB Ratio

Get a 7-Day Free Trial

8.67

7.21

2.64

2.58

1.85

Sino Biopharmaceutical Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
PB Ratio	Get a 7-Day Free Trial															2.64	2.42	2.58	1.75	1.85

Competitive Comparison of Sino Biopharmaceutical's PB Ratio

For the Biotechnology subindustry, Sino Biopharmaceutical's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Sino Biopharmaceutical's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Sino Biopharmaceutical's PB Ratio distribution charts can be found below:

* The bar in red indicates where Sino Biopharmaceutical's PB Ratio falls into.

Sino Biopharmaceutical PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Sino Biopharmaceutical's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	0.31495	/	0.227
	=	1.39

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Sino Biopharmaceutical (OTCPK:SBMFF) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Sino Biopharmaceutical PB Ratio Related Terms

Thank you for viewing the detailed overview of Sino Biopharmaceutical's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Sino Biopharmaceutical (Sino Biopharmaceutical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sino Biopharmaceutical Ltd (OTCPK:SBMFF) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

SBHMY:USA 01177:Hong Kong SMZ1:Germany

Address

1 Harbour Road, Unit 09, 41st Floor, Office Tower, Room 4109, Convention Plaza, Wanchai, Hong Kong, HKG

Website

https://www.sinobiopharm.com

Sino Biopharmaceutical Co, or SBP, is one of the largest drugmakers in China, with CNY 27 billion revenue in 2021. Its four most important therapeutic areas are oncology, hepatitis, cardio-cerebral, and respiratory medicines. SBP's current portfolio is mostly generics, and some key drugs are facing severe price reductions. However, it also has a rich pipeline of early-to-market generics and biosimilars, especially in oncology and respiratory treatments.